Product Liability
Pharmaceutical Drugs
Medical Devices
Mesothelioma
Types of Product Liability Claims
SSRI Antidepressants
Fosamax
Boniva
Nephrogenic Systemic Fibrosis
Yaz and Yasmin
Fen-Phen
Accutane
Reglan
Fen-Phen is a weight-loss drug that hasn't been available in the United States since the 1990s. It was discontinued after discovery that fenfluramine caused a 630% increased risk of developing primary pulmonary hypertension (PPH), a dangerous blood vessel disorder with no known cure. Fen-phen may also cause valvular heart disease in nearly 1 in 3 people. Cases of PPH are still being diagnosed as the result of taking Fen-Phen decades ago.
Symptoms of PPH include...
- Fatigue
- Weakness
- Shortness of Breath
- Hyperventilation
- Dizziness
- Fainting
- Blue coloring to lips, hands, and/or feet
- Coughing up Blood
If anyone who has taken Fen-Phen, no matter how long ago, experiences these or similar symptoms, a doctor should be consulted immediately. The development of PPH from Fen-Phen usage can take many years, even decades. Litigation for Fen-Phen injuries remains ongoing.